about
The Gastroprotective Role of Acanthus ilicifolius - A Study to Unravel the Underlying Mechanism of Anti-Ulcer Activity.Pharmacokinetic and Pharmacodynamic Features of Nanoemulsion Following Oral, Intravenous, Topical and Nasal Route.Improvement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platform.The use of nanoscaffolds and dendrimers in tissue engineering.Recent Update on Nanoemulgel as Topical Drug Delivery System.Recent advances in TPGS-based nanoparticles of docetaxel for improved chemotherapy.Arylamine N-acetyl Transferase (NAT) in the blue secretion of Telescopium telescopium: xenobiotic metabolizing enzyme as a biomarker for detection of environmental pollution.Development and validation of an HPLC-UV method for simultaneous determination of zidovudine, lamivudine, and nevirapine in human plasma and its application to pharmacokinetic study in human volunteers.Development and validation of RP-HPLC method: scope of application in the determination of oil solubility of paclitaxel.A comparative pharmacokinetic study of a fixed dose combination for essential hypertensive patients: a randomized crossover study in healthy human volunteers.Anti-inflammatory activity of Acanthus ilicifolius.Nanoemulsion strategy for olmesartan medoxomil improves oral absorption and extended antihypertensive activity in hypertensive rats.Comparative biodistribution and safety profiling of olmesartan medoxomil oil-in-water oral nanoemulsion.Nanotechnology based approaches for anti-diabetic drugs delivery.Safety against nephrotoxicity in paclitaxel treatment: Oral nanocarrier as an effective tool in preclinical evaluation with marked in vivo antitumor activity.Development and Validation of an LC-MS/MS-ESI Method for Comparative Pharmacokinetic Study of Ciprofloxacin in Healthy Male Subjects.Hyaluronic acid-modified betamethasone encapsulated polymeric nanoparticles: fabrication, characterisation, in vitro release kinetics, and dermal targeting.Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends.An update on natural compounds in the remedy of diabetes mellitus: A systematic review.Paclitaxel loaded vitamin E-TPGS nanoparticles for cancer therapyThe use of nanoparticles as biomaterials in dentistryDendrimer entrapped microsponge gel of dithranol for effective topical treatmentCarbon nanotube scaffolds as emerging nanoplatform for myocardial tissue regeneration: A review of recent developments and therapeutic implicationsPerspectives of Nanoemulsion Strategies in The Improvement of Oral, Parenteral and Transdermal ChemotherapyAn overview of application of silver nanoparticles for biomaterials in dentistryType-3c Diabetes Mellitus, Diabetes of Exocrine Pancreas - An UpdateThe potential of dendrimer in delivery of therapeutics for dentistryAdvanced nanoscale carrier-based approaches to overcome biopharmaceutical issues associated with anticancer drug 'Etoposide'Rising horizon in circumventing multidrug resistance in chemotherapy with nanotechnologyAdenosine Receptors in Modulation of Central Nervous System DisordersTargeted drug delivery to the brain via intranasal nanoemulsion: Available proof of concept and existing challengesAdenosine Receptors as Novel Targets for the Treatment of Various CancersStrategizing biodegradable polymeric nanoparticles to cross the biological barriers for cancer targetingRole of therapeutic agents on repolarisation of tumour-associated macrophage to halt lung cancer progression
P50
Q36248965-833DBAD8-AC12-45DC-AB24-AE1B20E49261Q39026128-8DF7E5A6-BBF0-4437-ACDA-597A4ED6F382Q39062649-CDE3201F-8D6E-4379-B27E-BFCAC29C8A9BQ39144645-F5BB0B1A-CE8C-49E0-BCFC-27BB04AE0771Q39244717-247351D0-A407-4B1E-9B41-E47EF44609B6Q39437182-261E4D60-D76A-4D0E-BFCE-5139FD3F990CQ41289232-24A71819-511D-49D4-B81A-34E6987BC8BCQ43771088-CBCC853D-C42F-4695-9E2F-963D1BBD449EQ45450035-5FF65EC6-C759-4FFD-9783-8FA96223D178Q45987726-2DA1466B-A946-414D-A8A0-147107655C44Q46429654-570114F2-FBAD-4F83-9ABF-53C555F55CC4Q46523213-59385939-2B72-4C00-BA2C-5226AF049CE6Q48439471-41A65CD9-0A09-4829-BCEA-268809A49D64Q49357714-91095700-6613-4F6C-AB4F-E287B982C09FQ50101525-604DB63E-86D2-4F81-A9C7-743BEFEA96CFQ51072905-EC5388B2-ACB3-44DE-8FF6-FB01BB3D9F89Q51737572-926598AD-4D92-4087-9D60-6C4B6DB39DECQ55456813-E7C21ADF-C722-4F71-8F92-FD4053A084E1Q55503289-5B50DC4A-CAFE-4429-B13A-8E13501255CAQ57143271-ADC276B2-E7D0-4835-AC4D-B2432F46CF56Q57166466-1B3CFAB0-05DC-4C65-ACB7-6279993F6024Q64070544-56F9215B-769D-40DD-8B09-DC8DE6010345Q88816017-5C882426-54F1-4790-AAD2-F54658402EEDQ89012647-581F5CA9-E52F-4EE5-9D29-577C41707A29Q90393666-E79A0AA1-66B8-4F15-9797-B7284B8487EBQ91068796-E2B95F79-5D98-4C8F-8E7C-88C6B1CC1ADCQ91115240-4615AA66-7170-489F-8914-8E7DD62E4783Q91383163-A786740B-FF94-4DEA-A3C1-B49F710AA59EQ91564962-0DA86DE2-A5E5-4B0A-B945-FEFC3E5F2A5EQ91917101-7E8ABC76-BA54-450B-9676-5CB870976C96Q92077990-74E14431-83D7-481F-863A-D9D1E6482FCCQ92102286-97529EBA-F544-4C7C-B030-502A0F9FE8B7Q92131432-F7938D82-1206-4832-A4D3-77E5ABB01772Q92144462-AFEA7DEF-F85D-4E1C-AAEF-2341F5389800
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Bapi Gorain
@ast
Bapi Gorain
@en
Bapi Gorain
@es
Bapi Gorain
@nl
Bapi Gorain
@sl
type
label
Bapi Gorain
@ast
Bapi Gorain
@en
Bapi Gorain
@es
Bapi Gorain
@nl
Bapi Gorain
@sl
altLabel
Bapi
@en
prefLabel
Bapi Gorain
@ast
Bapi Gorain
@en
Bapi Gorain
@es
Bapi Gorain
@nl
Bapi Gorain
@sl
P108
P1053
M-9706-2017
P106
P1153
55697999900
P31
P3829
P496
0000-0002-8487-1748